Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 11 - 14    source : Www.hutch-med.com    save search
HUTCHMED Announces Positive Topline Result in Fruquintinib Phase III FRUTIGA Study in Second-Line Gastric Cancer in China
Published: 2022-11-14 (Crawled : 00:00) - hutch-med.com
LLY | $750.77 -0.12% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
 | | O: 1.92% H: 0.48% C: -0.84%
BGNE S | $138.39 -2.06% -2.1% 230K twitter stocktwits trandingview |
Health Technology
 | | O: 3.05% H: 1.74% C: -0.5%
topline china positive cancer study
Gainers vs Losers
49% 51%

Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M twitter stocktwits trandingview |
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M twitter stocktwits trandingview |
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M twitter stocktwits trandingview |
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M twitter stocktwits trandingview |

HUBC | $1.94 49.23% 32.99% 73M twitter stocktwits trandingview |
n/a
SPCB | $0.4044 46.52% 31.75% 130M twitter stocktwits trandingview |
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M twitter stocktwits trandingview |
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M twitter stocktwits trandingview |
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M twitter stocktwits trandingview |

AMBI | $3.72 -26.77% 21.77% 9.8K twitter stocktwits trandingview |
n/a
Your saved searches
Save your searches and get alerts when important news are released.